
Sign up to save your podcasts
Or


Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.
By The Spondylitis Association of America (SAA)4.8
3131 ratings
Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.

91,129 Listeners

38,937 Listeners

5,101 Listeners

87,779 Listeners

112,741 Listeners

56,533 Listeners

14,956 Listeners

9,277 Listeners

8,896 Listeners

57,890 Listeners

29,203 Listeners

16,120 Listeners

41,570 Listeners

10,818 Listeners

1,190 Listeners